Ten-year real-world outcomes of antivascular endothelial growth factor therapy in neovascular age-related macular degeneration using pro re nata regimen.
Pekko HujanenHeikki RuhaEemil LehtonenInka PirinenHeini HuhtalaAnu VaajanenUlla SyvänenAnja TuulonenHannele Uusitalo-JärvinenPublished in: BMJ open ophthalmology (2023)
VA was maintained short-term and long-term with anti-VEGF therapy using PRN treatment regimen.